These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 7285305

  • 1. Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.
    Freed MD, Heymann MA, Lewis AB, Roehl SL, Kensey RC.
    Circulation; 1981 Nov; 64(5):899-905. PubMed ID: 7285305
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacologic use of prostaglandin E1 in infant with congenital heart disease.
    Heymann MA.
    Am Heart J; 1981 Jun; 101(6):837-43. PubMed ID: 7234660
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.
    Heymann MA, Clyman RI.
    Pharmacotherapy; 1982 Jun; 2(3):148-55. PubMed ID: 6763200
    [Abstract] [Full Text] [Related]

  • 4. Role of prostaglandin E1 and E2 in the management of neonatal heart disease.
    Olley PM, Coceani F, Rowe RD.
    Adv Prostaglandin Thromboxane Res; 1978 Jun; 4():345-53. PubMed ID: 645511
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of prostaglandins and blockers of prostaglandin synthesis on the ductus arteriosus: animal and human studies.
    Heymann MA, Rudolph AM.
    Adv Prostaglandin Thromboxane Res; 1978 Jun; 4():363-72. PubMed ID: 645512
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of prostaglandin E1 for emergency palliation of symptomatic coarctation of the Aorta.
    Graham TP, Atwood GF, Boucek RJ.
    Cathet Cardiovasc Diagn; 1978 Jun; 4(1):97-102. PubMed ID: 77192
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.
    Olley PM, Coceani F, Bodach E.
    Circulation; 1976 Apr; 53(4):728-31. PubMed ID: 56243
    [Abstract] [Full Text] [Related]

  • 14. Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.
    Park IS, Nihill MR, Titus JL.
    J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):471-5. PubMed ID: 6681824
    [No Abstract] [Full Text] [Related]

  • 15. Prostaglandin and damage to ductus arteriosus.
    Moulaert AJ, Gittenberger AC, Harinck E.
    Lancet; 1977 Mar 26; 1(8013):703-4. PubMed ID: 66503
    [No Abstract] [Full Text] [Related]

  • 16. Editorial: Nonsurgical palliation of congenital heart malformations.
    Olley PM.
    N Engl J Med; 1975 Jun 12; 292(24):1292-4. PubMed ID: 48193
    [No Abstract] [Full Text] [Related]

  • 17. Prostaglandins and the management of congenital heart disease.
    Taylor WJ, Alpert BS.
    Am Fam Physician; 1982 Dec 12; 26(6):127-32. PubMed ID: 6890758
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prostaglandin E1 infusion: successful initial treatment.
    Linday L, Levin AR, Reitman M, Engle MA.
    N Y State J Med; 1981 Feb 12; 81(2):218-21. PubMed ID: 6936640
    [No Abstract] [Full Text] [Related]

  • 20. Administration of prostaglandin E1 in neonates with critical congenital cardiac defects.
    Lewis AB, Takahashi M, Lurie PR.
    J Pediatr; 1978 Sep 12; 93(3):481-5. PubMed ID: 690772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.